AVANIR PHARMACEUTICALS
AVANIR PHARMACEUTICALS (AVNR) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 350 transactions totaling $75.9M, demonstrating a bearish sentiment with -$71.8M in net insider flow. The most recent transaction on Dec 18, 2014 involved a sale of 5,780 shares valued at $97.9K.
AVNR Insider Activity Summary
Who Is Buying AVNR Stock?
No significant insider buying has been recorded for AVNR in the recent period.
Who Is Selling AVNR Stock?
No significant insider selling has been recorded for AVNR in the recent period.
Is AVANIR PHARMACEUTICALS Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for AVNR is bearish with an Insider Alignment Score of 3/100 and a net flow of -$71.8M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
AVNR Frequently Asked Questions
Understanding AVNR Insider Activity
Insider trading at AVANIR PHARMACEUTICALS (AVNR) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading AVNR stock, having executed 350 transactions in the past 90 days. The most active insider is Nicholas Galakatos (Executive), who has made 7 transactions totaling $34.2M.
Related Tools
Track AVANIR PHARMACEUTICALS Insider Activity
Get notified when executives and directors at AVNR file new Form 4 transactions